Navigation Links
Collagen Matrix, Inc. Receives FDA 510(k) Clearance for TenoMend(TM) Collagen Tendon Wrap for the Management and Protection of Tendon Injuries
Date:5/27/2008

FRANKLIN LAKES, N.J., May 27 /PRNewswire/ -- Collagen Matrix, Inc. announced today that it has received the United States Food and Drug Administration's 510(k) clearance of its TenoMend(TM) Collagen Tendon Wrap indicated for the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue.

TenoMend(TM) Collagen Tendon Wrap is a resorbable type 1 collagen matrix that provides a non-constricting encasement for injured tendons. TenoMend(TM) Collagen Tendon Wrap is designed to be an interface between the tendon and tendon sheath or the surrounding tissue. When hydrated, TenoMend(TM) Collagen Tendon Wrap is a conformable, nonfriable, self-curling collagen sheet designed for easy placement under, around or over the injured tendon. The patented self-curling wrap design offers the ability to implant with minimal suturing. The device provides a protected environment and gliding surface of the sheath for tendon healing.

In trauma cases, fractures and injuries of bones in the extremities typically result in injury of the associated soft tissue such as tendon and peripheral nerves. Tendon scarring can often occur as a result of tendon repair. When tendon scarring occurs, other structures such as joints may lose normal range of motion.

Collagen Matrix's portfolio of orthopaedic products now includes solutions for bone, tendon, and peripheral nerve repair. With Collagen Matrix's OssiGuide(TM) Cancellous Granules, OssiMend(TM) and OssiMend(TM) Putty Mineral-Collagen Composites, OssiPatch(TM) Bone Healing Protective Sheet, NeuroMatrix(TM) Collagen Nerve Conduit, Neuroflex(TM) Flexible Collagen Nerve Conduit, NeuroMend(TM) Collagen Nerve Wrap and TenoMend(TM) Collagen Tendon Wrap, the surgeon is equipped with the products needed to repair a complex injury.

The results of an animal flexor tendon repair study using TenoMend(TM) Collagen Tendon Wrap demonstrated the ease of implantation with the tendon's re
'/>"/>

SOURCE Collagen Matrix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Galderma Completes Acquisition of CollaGenex
2. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
3. Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications
4. TEI Biosciences Launches SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction
5. Jarrow Formulas Launches New Products Featuring BioCell Collagen II(R)
6. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
7. BMP Sunstone Receives Import Drug License (IDL) from SFDA
8. Nikon Instruments Receives Record Number of Entries for Nikon Small World
9. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. febit Receives U.S. Patent for Microfluidic Extraction Method
11. Prime Therapeutics Receives VIPPS Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... 25, 2014 The report “Service Quality ... Type & Provider Type - Global Advancements, Worldwide Forecasts ... an in-depth analysis and forecasting of revenues. , ... 221 pages and in-depth TOC on “Service Quality Management ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
(Date:12/24/2014)... Solutions , Inc. (NASDAQ: BLFS ), a leading ... storage and cryopreservation freeze media and ... or the "Company"), today announced that it will hold its ... "Annual Meeting"). Because the expected date for the ...
(Date:12/24/2014)... 2014 GMO corn cases filed across the ... the process of being consolidated in a Kansas federal court ... AG MIR 162 Corn Litigation, MDL No. 2591 in the ... of the Syngenta GMO corn multidistrict litigation (MDL) has been ...
Breaking Biology Technology:Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
... In the event of an outbreak or a ... for virulence or drug resistance is essential to mounting ... of a pathogen genome is time-intensive and likely impractical ... a comparative genomics strategy to drastically reduce the time ...
... by Israel,s Minister of, Communications to the Company,s Headquarters ... and Strategy for Entering Israel,s Cellular Market, PETACH ... Minister of Communications, Mr. Ariel Etias, to the offices ... Smile,s,CEO, Ms. Stella Hendler, presented the Company,s vision and ...
... prescription drugs that,exceeded $20 billion in sales in 2006, that ... years. Prescription to OTC switches,were frequent in 2006 and 2007 ... Rx to OTC Switch: Market Analysis and Product Management,Strategies, predicts ... OTC are forecast to reach $5 billion in 2008 and,increase ...
Cached Biology Technology:Scientists develop strategy to rapidly describe outbreak strains with next-generation DNA sequencing 2Having Penetrated Israel's Domestic Telephony Market, 012 Smile.Communications Prepares for Its Next Goal: Entering Israel's Cellular Market 2Having Penetrated Israel's Domestic Telephony Market, 012 Smile.Communications Prepares for Its Next Goal: Entering Israel's Cellular Market 3Use of Rx to OTC Switch as Product Management Tactic Enjoys Comeback 2
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics company, today ... in genetic ancestry of individuals from across the ... more than four hundred years ago, the United ... peoples from different continents. This study illuminates how American history ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense Logistics Agency ... detect and prevent counterfeit microcircuits from entering into its ... an in-house microcircuit anti-counterfeit initiative dubbed DNA marking. The ... increasing their reliability throughout the supply chain. The new ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in this market ... applications. Chemical sensors help in recording of patient data ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... the Carnegie Institution,s Department of Global Ecology have taken ... the warming planet. So-called geoengineering ideaslarge-scale projects to change ... to reflect solar radiation, injecting aerosols of sulfate into ... more. Past modeling of the sulfate idea looked at ...
... Amid growing concern that synthetic life sciences pose biosecurity ... DNA sequence trade. Research published today in the ... looks at the necessity of a global regulator for ... Synthetic life sciences are making breakthroughs at a ...
... for Neuroscience Research at Children,s National Medical Center ... pathways activated during brain cell developmentthe epidermal growth factor ... how many and which types of brain cells are ... brains. This knowledge may help scientists design new ways ...
Cached Biology News:Optimizing climate change reduction 2Technology to screen for synbio abuses lags 2Technology to screen for synbio abuses lags 3Discovery of key pathway interaction may lead to therapies that aid brain growth and repair 2
Porcine parvovirus and mycoplasma tested. Contains 0.5 g/L of trypsin (1:250) and 0.2 g/L of EDTA4Na in Hanks' Balanced Salt Solution without CaCl2 MgCl2 6H2O and MgSO4 7H2O. Contains phenol red....
...
... carry the kanamycin resistance gene that confers ... generation of multiple insertion events can be ... Geneticin Reagent. Pichia transformants are selected on ... of resistance to Geneticin Reagent. The ability ...
Immunogen: Synthetic peptide: R(89) L A F T V D D N P T K P T T R Q R Y(107) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: